 | • レポートコード：D0GIR-00303 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、HIVワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。HIVワクチンの種類別市場規模（フェーズI、フェーズII、フェーズIII）、用途別市場規模（研究所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Argos Therapeutics、Glaxosmithkline、Genecure、Bionor Pharma、Inovio Pharmaceuticals、Janssen Global Services、Paxvax Corporation、Geovax,、Sanofi ・地域別グローバル市場分析 2015年-2020年 ・HIVワクチンの北米市場（アメリカ、カナダ、メキシコ） ・HIVワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・HIVワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・HIVワクチンの南米市場（ブラジル、アルゼンチン） ・HIVワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：フェーズI、フェーズII、フェーズIII ・用途別分析：研究所、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global HIV Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The HIV Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
HIV Vaccines market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, HIV Vaccines market has been segmented into:
Phase I
Phase II
Phase III
By Application, HIV Vaccines has been segmented into:
Research Institute
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global HIV Vaccines market presented in the report. This section sheds light on the sales growth of different regional and country-level HIV Vaccines markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global HIV Vaccines market.
The report offers in-depth assessment of the growth and other aspects of the HIV Vaccines market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and HIV Vaccines Market Share Analysis
HIV Vaccines competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, HIV Vaccines sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the HIV Vaccines sales, revenue and market share for each player covered in this report.
The major players covered in HIV Vaccines are:
Argos Therapeutics
Glaxosmithkline
Genecure
Bionor Pharma
Inovio Pharmaceuticals
Janssen Global Services
Paxvax Corporation
Geovax,
Sanofi
Table of Contents
1 HIV Vaccines Market Overview
1.1 Product Overview and Scope of HIV Vaccines
1.2 Classification of HIV Vaccines by Type
1.2.1 Global HIV Vaccines Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global HIV Vaccines Revenue Market Share by Type in 2019
1.2.3 Phase I
1.2.4 Phase II
1.2.5 Phase III
1.3 Global HIV Vaccines Market by Application
1.3.1 Overview: Global HIV Vaccines Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Research Institute
1.3.3 Other
1.4 Global HIV Vaccines Market by Regions
1.4.1 Global HIV Vaccines Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of HIV Vaccines (2015-2025)
1.4.3 North America (USA, Canada and Mexico) HIV Vaccines Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) HIV Vaccines Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) HIV Vaccines Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) HIV Vaccines Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) HIV Vaccines Status and Prospect (2015-2025)
2 Company Profiles
2.1 Argos Therapeutics
2.1.1 Argos Therapeutics Details
2.1.2 Argos Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Argos Therapeutics SWOT Analysis
2.1.4 Argos Therapeutics Product and Services
2.1.5 Argos Therapeutics HIV Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.2 Glaxosmithkline
2.2.1 Glaxosmithkline Details
2.2.2 Glaxosmithkline Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Glaxosmithkline SWOT Analysis
2.2.4 Glaxosmithkline Product and Services
2.2.5 Glaxosmithkline HIV Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.3 Genecure
2.3.1 Genecure Details
2.3.2 Genecure Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Genecure SWOT Analysis
2.3.4 Genecure Product and Services
2.3.5 Genecure HIV Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bionor Pharma
2.4.1 Bionor Pharma Details
2.4.2 Bionor Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bionor Pharma SWOT Analysis
2.4.4 Bionor Pharma Product and Services
2.4.5 Bionor Pharma HIV Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.5 Inovio Pharmaceuticals
2.5.1 Inovio Pharmaceuticals Details
2.5.2 Inovio Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Inovio Pharmaceuticals SWOT Analysis
2.5.4 Inovio Pharmaceuticals Product and Services
2.5.5 Inovio Pharmaceuticals HIV Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.6 Janssen Global Services
2.6.1 Janssen Global Services Details
2.6.2 Janssen Global Services Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Janssen Global Services SWOT Analysis
2.6.4 Janssen Global Services Product and Services
2.6.5 Janssen Global Services HIV Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.7 Paxvax Corporation
2.7.1 Paxvax Corporation Details
2.7.2 Paxvax Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Paxvax Corporation SWOT Analysis
2.7.4 Paxvax Corporation Product and Services
2.7.5 Paxvax Corporation HIV Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.8 Geovax,
2.8.1 Geovax, Details
2.8.2 Geovax, Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Geovax, SWOT Analysis
2.8.4 Geovax, Product and Services
2.8.5 Geovax, HIV Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Sanofi SWOT Analysis
2.9.4 Sanofi Product and Services
2.9.5 Sanofi HIV Vaccines Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global HIV Vaccines Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 HIV Vaccines Players Market Share
3.2.2 Top 10 HIV Vaccines Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global HIV Vaccines Revenue and Market Share by Regions
4.2 North America HIV Vaccines Revenue and Growth Rate (2015-2020)
4.3 Europe HIV Vaccines Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific HIV Vaccines Revenue and Growth Rate (2015-2020)
4.5 South America HIV Vaccines Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa HIV Vaccines Revenue and Growth Rate (2015-2020)
5 North America HIV Vaccines Revenue by Countries
5.1 North America HIV Vaccines Revenue by Countries (2015-2020)
5.2 USA HIV Vaccines Revenue and Growth Rate (2015-2020)
5.3 Canada HIV Vaccines Revenue and Growth Rate (2015-2020)
5.4 Mexico HIV Vaccines Revenue and Growth Rate (2015-2020)
6 Europe HIV Vaccines Revenue by Countries
6.1 Europe HIV Vaccines Revenue by Countries (2015-2020)
6.2 Germany HIV Vaccines Revenue and Growth Rate (2015-2020)
6.3 UK HIV Vaccines Revenue and Growth Rate (2015-2020)
6.4 France HIV Vaccines Revenue and Growth Rate (2015-2020)
6.5 Russia HIV Vaccines Revenue and Growth Rate (2015-2020)
6.6 Italy HIV Vaccines Revenue and Growth Rate (2015-2020)
7 Asia-Pacific HIV Vaccines Revenue by Countries
7.1 Asia-Pacific HIV Vaccines Revenue by Countries (2015-2020)
7.2 China HIV Vaccines Revenue and Growth Rate (2015-2020)
7.3 Japan HIV Vaccines Revenue and Growth Rate (2015-2020)
7.4 Korea HIV Vaccines Revenue and Growth Rate (2015-2020)
7.5 India HIV Vaccines Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia HIV Vaccines Revenue and Growth Rate (2015-2020)
8 South America HIV Vaccines Revenue by Countries
8.1 South America HIV Vaccines Revenue by Countries (2015-2020)
8.2 Brazil HIV Vaccines Revenue and Growth Rate (2015-2020)
8.3 Argentina HIV Vaccines Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue HIV Vaccines by Countries
9.1 Middle East & Africa HIV Vaccines Revenue by Countries (2015-2020)
9.2 Saudi Arabia HIV Vaccines Revenue and Growth Rate (2015-2020)
9.3 UAE HIV Vaccines Revenue and Growth Rate (2015-2020)
9.4 Egypt HIV Vaccines Revenue and Growth Rate (2015-2020)
9.5 South Africa HIV Vaccines Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global HIV Vaccines Revenue and Market Share by Type (2015-2020)
10.2 Global HIV Vaccines Market Forecast by Type (2019-2024)
10.3 Phase I Revenue Growth Rate (2015-2025)
10.4 Phase II Revenue Growth Rate (2015-2025)
10.5 Phase III Revenue Growth Rate (2015-2025)
11 Global HIV Vaccines Market Segment by Application
11.1 Global HIV Vaccines Revenue Market Share by Application (2015-2020)
11.2 HIV Vaccines Market Forecast by Application (2019-2024)
11.3 Research Institute Revenue Growth (2015-2020)
11.4 Other Revenue Growth (2015-2020)
12 Global HIV Vaccines Market Size Forecast (2021-2025)
12.1 Global HIV Vaccines Market Size Forecast (2021-2025)
12.2 Global HIV Vaccines Market Forecast by Regions (2021-2025)
12.3 North America HIV Vaccines Revenue Market Forecast (2021-2025)
12.4 Europe HIV Vaccines Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific HIV Vaccines Revenue Market Forecast (2021-2025)
12.6 South America HIV Vaccines Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa HIV Vaccines Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global HIV Vaccines Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of HIV Vaccines by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global HIV Vaccines Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market HIV Vaccines Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Argos Therapeutics Corporate Information, Location and Competitors
Table 6. Argos Therapeutics HIV Vaccines Major Business
Table 7. Argos Therapeutics HIV Vaccines Total Revenue (USD Million) (2017-2018)
Table 8. Argos Therapeutics SWOT Analysis
Table 9. Argos Therapeutics HIV Vaccines Product and Solutions
Table 10. Argos Therapeutics HIV Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Glaxosmithkline Corporate Information, Location and Competitors
Table 12. Glaxosmithkline HIV Vaccines Major Business
Table 13. Glaxosmithkline HIV Vaccines Total Revenue (USD Million) (2018-2019)
Table 14. Glaxosmithkline SWOT Analysis
Table 15. Glaxosmithkline HIV Vaccines Product and Solutions
Table 16. Glaxosmithkline HIV Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Genecure Corporate Information, Location and Competitors
Table 18. Genecure HIV Vaccines Major Business
Table 19. Genecure HIV Vaccines Total Revenue (USD Million) (2017-2018)
Table 20. Genecure SWOT Analysis
Table 21. Genecure HIV Vaccines Product and Solutions
Table 22. Genecure HIV Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Bionor Pharma Corporate Information, Location and Competitors
Table 24. Bionor Pharma HIV Vaccines Major Business
Table 25. Bionor Pharma HIV Vaccines Total Revenue (USD Million) (2017-2018)
Table 26. Bionor Pharma SWOT Analysis
Table 27. Bionor Pharma HIV Vaccines Product and Solutions
Table 28. Bionor Pharma HIV Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Inovio Pharmaceuticals Corporate Information, Location and Competitors
Table 30. Inovio Pharmaceuticals HIV Vaccines Major Business
Table 31. Inovio Pharmaceuticals HIV Vaccines Total Revenue (USD Million) (2017-2018)
Table 32. Inovio Pharmaceuticals SWOT Analysis
Table 33. Inovio Pharmaceuticals HIV Vaccines Product and Solutions
Table 34. Inovio Pharmaceuticals HIV Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Janssen Global Services Corporate Information, Location and Competitors
Table 36. Janssen Global Services HIV Vaccines Major Business
Table 37. Janssen Global Services HIV Vaccines Total Revenue (USD Million) (2017-2018)
Table 38. Janssen Global Services SWOT Analysis
Table 39. Janssen Global Services HIV Vaccines Product and Solutions
Table 40. Janssen Global Services HIV Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Paxvax Corporation Corporate Information, Location and Competitors
Table 42. Paxvax Corporation HIV Vaccines Major Business
Table 43. Paxvax Corporation HIV Vaccines Total Revenue (USD Million) (2017-2018)
Table 44. Paxvax Corporation SWOT Analysis
Table 45. Paxvax Corporation HIV Vaccines Product and Solutions
Table 46. Paxvax Corporation HIV Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Geovax, Corporate Information, Location and Competitors
Table 48. Geovax, HIV Vaccines Major Business
Table 49. Geovax, HIV Vaccines Total Revenue (USD Million) (2017-2018)
Table 50. Geovax, SWOT Analysis
Table 51. Geovax, HIV Vaccines Product and Solutions
Table 52. Geovax, HIV Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Sanofi Corporate Information, Location and Competitors
Table 54. Sanofi HIV Vaccines Major Business
Table 55. Sanofi HIV Vaccines Total Revenue (USD Million) (2017-2018)
Table 56. Sanofi SWOT Analysis
Table 57. Sanofi HIV Vaccines Product and Solutions
Table 58. Sanofi HIV Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Global HIV Vaccines Revenue (Million USD) by Players (2015-2020)
Table 60. Global HIV Vaccines Revenue Share by Players (2015-2020)
Table 61. Global HIV Vaccines Revenue (Million USD) by Regions (2015-2020)
Table 62. Global HIV Vaccines Revenue Market Share by Regions (2015-2020)
Table 63. North America HIV Vaccines Revenue by Countries (2015-2020)
Table 64. North America HIV Vaccines Revenue Market Share by Countries (2015-2020)
Table 65. Europe HIV Vaccines Revenue (Million USD) by Countries (2015-2020)
Table 66. Asia-Pacific HIV Vaccines Revenue (Million USD) by Countries (2015-2020)
Table 67. South America HIV Vaccines Revenue by Countries (2015-2020)
Table 68. South America HIV Vaccines Revenue Market Share by Countries (2015-2020)
Table 69. Middle East and Africa HIV Vaccines Revenue (Million USD) by Countries (2015-2020)
Table 70. Middle East and Africa HIV Vaccines Revenue Market Share by Countries (2015-2020)
Table 71. Global HIV Vaccines Revenue (Million USD) by Type (2015-2020)
Table 72. Global HIV Vaccines Revenue Share by Type (2015-2020)
Table 73. Global HIV Vaccines Revenue Forecast by Type (2021-2025)
Table 74. Global HIV Vaccines Revenue by Application (2015-2020)
Table 75. Global HIV Vaccines Revenue Share by Application (2015-2020)
Table 76. Global HIV Vaccines Revenue Forecast by Application (2021-2025)
Table 77. Global HIV Vaccines Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. HIV Vaccines Picture
Figure 2. Global HIV Vaccines Revenue Market Share by Type in 2019
Figure 3. Phase I Picture
Figure 4. Phase II Picture
Figure 5. Phase III Picture
Figure 6. HIV Vaccines Revenue Market Share by Application in 2019
Figure 7. Research Institute Picture
Figure 8. Other Picture
Figure 9. Global HIV Vaccines Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America HIV Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe HIV Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific HIV Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America HIV Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa HIV Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global HIV Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global HIV Vaccines Revenue Share by Players in 2019
Figure 17. Global Top 5 Players HIV Vaccines Revenue Market Share in 2019
Figure 18. Global Top 10 Players HIV Vaccines Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global HIV Vaccines Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global HIV Vaccines Revenue Market Share by Regions (2015-2020)
Figure 22. Global HIV Vaccines Revenue Market Share by Regions in 2018
Figure 23. North America HIV Vaccines Revenue and Growth Rate (2015-2020)
Figure 24. Europe HIV Vaccines Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific HIV Vaccines Revenue and Growth Rate (2015-2020)
Figure 26. South America HIV Vaccines Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa HIV Vaccines Revenue and Growth Rate (2015-2020)
Figure 28. North America HIV Vaccines Revenue Market Share by Countries (2015-2020)
Figure 29. North America HIV Vaccines Revenue Market Share by Countries in 2019
Figure 30. USA HIV Vaccines Revenue and Growth Rate (2015-2020)
Figure 31. Canada HIV Vaccines Revenue and Growth Rate (2015-2020)
Figure 32. Mexico HIV Vaccines Revenue and Growth Rate (2015-2020)
Figure 33. Europe HIV Vaccines Revenue Market Share by Countries (2015-2020)
Figure 34. Europe HIV Vaccines Revenue Market Share by Countries in 2019
Figure 35. Germany HIV Vaccines Revenue and Growth Rate (2015-2020)
Figure 36. UK HIV Vaccines Revenue and Growth Rate (2015-2020)
Figure 37. France HIV Vaccines Revenue and Growth Rate (2015-2020)
Figure 38. Russia HIV Vaccines Revenue and Growth Rate (2015-2020)
Figure 39. Italy HIV Vaccines Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific HIV Vaccines Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific HIV Vaccines Revenue Market Share by Countries in 2019
Figure 42. China HIV Vaccines Revenue and Growth Rate (2015-2020)
Figure 43. Japan HIV Vaccines Revenue and Growth Rate (2015-2020)
Figure 44. Korea HIV Vaccines Revenue and Growth Rate (2015-2020)
Figure 45. India HIV Vaccines Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia HIV Vaccines Revenue and Growth Rate (2015-2020)
Figure 47. South America HIV Vaccines Revenue Market Share by Countries (2015-2020)
Figure 48. South America HIV Vaccines Revenue Market Share by Countries in 2019
Figure 49. Brazil HIV Vaccines Revenue and Growth Rate (2015-2020)
Figure 50. Argentina HIV Vaccines Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa HIV Vaccines Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa HIV Vaccines Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia HIV Vaccines Revenue and Growth Rate (2015-2020)
Figure 54. UAE HIV Vaccines Revenue and Growth Rate (2015-2020)
Figure 55. Egypt HIV Vaccines Revenue and Growth Rate (2015-2020)
Figure 56. South Africa HIV Vaccines Revenue and Growth Rate (2015-2020)
Figure 57. Global HIV Vaccines Revenue Share by Type (2015-2020)
Figure 58. Global HIV Vaccines Revenue Share by Type in 2019
Figure 59. Global HIV Vaccines Market Share Forecast by Type (2021-2025)
Figure 60. Global Phase I Revenue Growth Rate (2015-2020)
Figure 61. Global Phase II Revenue Growth Rate (2015-2020)
Figure 62. Global Phase III Revenue Growth Rate (2015-2020)
Figure 63. Global HIV Vaccines Revenue Share by Application (2015-2020)
Figure 64. Global HIV Vaccines Revenue Share by Application in 2019
Figure 65. Global HIV Vaccines Market Share Forecast by Application (2021-2025)
Figure 66. Global Research Institute Revenue Growth Rate (2015-2020)
Figure 67. Global Other Revenue Growth Rate (2015-2020)
Figure 68. Global HIV Vaccines Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global HIV Vaccines Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global HIV Vaccines Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America HIV Vaccines Revenue Market Forecast (2021-2025)
Figure 72. Europe HIV Vaccines Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific HIV Vaccines Revenue Market Forecast (2021-2025)
Figure 74. South America HIV Vaccines Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa HIV Vaccines Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
薬剤・ワクチン臨床試験の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Clinical Trials of Drugs and Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value cha…- DPTワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global DPT Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The DPT Vaccines market report provi…
- 細菌ワクチンの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Bacterial Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bacterial Vaccines market …
- 結合型ワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Conjugate Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.2% in the forecast period of 2020 to 2025 and will expected to reach USD 14570 million by 2025, from USD 11890 million in 2019. The Conjugate Vaccines …
- 予防B型肝炎ウイルスワクチンの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Prophylactic Hepatitis B Virus Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Proph…